Drug
Arm 1 Ntla 5001
Arm 1 Ntla 5001: highest development phase Phase 1/2, developed by Intellia Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Intellia Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Arm 1: NTLA-5001 NCT05066165 | Phase 1/2 | Acute Myeloid Leukemia |
Latest
No recent events.
Follow Arm 1 Ntla 5001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.